Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
50 Cards in this Set
- Front
- Back
describe the pathway of heme breakdown
|
macrophage eats RBC > globin > broken down to heme > bilirubin (insoluble) > bound to albumin (soluble) > conjugated to glucaronic acid in the liver > secreted to bile > bacteria convert to urobilinogen
|
|
explain how to measure bilirubin
|
direct/indirect bilirubin
direct - conjugated indirect - both direct and indirect |
|
four primary causes of jaundice
|
1. physiological, 2. antibody against fetal RBC, 3. hereditary hemolytic disorder, 4. gilbert's
|
|
what is kernicterus
|
elevated unconjugated bilirubin, can penetrate immature fetal BBB to cause brain damage (binds to plasma membrane), treat with phototherapy
|
|
describe heme synthesis pathway, and one pathology that can occur
|
glycine + succinyl CoA with ALA synthase makes ALA, then converted to heme
lead poisoning inhibits pathway from ALA > heme, results in elevated ALA |
|
describe two types of porphyria and pathogenesis
|
1. primary - hereditary, autosomal dominant; a) acute - early step defect (ALA build-up), b) cutaneous - late step, sunlight converts intermediate to toxic compounds
2. secondary/acquired - chemical effect (eg Pb poisoning) |
|
what cytoplasmic molecule binds iron
what plasma molecule binds iron |
apoferritin, forms ferritin after binding
transferrin |
|
explain how ferritin can be used as a diagnostic tool
|
indicator of iron storage, except in inflammatory states where ferritin levels will be increased
|
|
name three primary causes of anemia
|
1. iron deficiency, 2. defective iron storage, 3. defective Fe utilization
|
|
what is hepcidin, explain pathology associated with this
|
binds to ferroportin and causes internalization/degradation of the protein, so cannot export iron into blood, causes iron deficiency
|
|
explain sideroblastic anemia
|
can be hereditary or acquired; inability to incorporate Fe into hemoglobin, leads to excess ferritin that accumulates into hemosiderin, this can cause organ damage
|
|
explain pathology of hemochromatosis
|
hereditary; excessive Fe absorption due to underactive hepcidin; caused by mutation in hepcidin or regulatory gene (HFE) [primary method]
|
|
how does excretion of ammonia occur
|
liver converts NH3 to urea, excreted by kidneys or intestine
|
|
what is the important amino acid in urea formation
|
ornithine
|
|
where does urea cycle take place
|
liver
|
|
describe hereditary hyperammonia
|
defect in enzymes of urea cycle, causes excretion of intermediates, but this exhausts ornithine since it is not regenerated
|
|
describe treatment of hyperammonia
|
low-protein diet, arginine (ornithine replacement), high carbohydrate diet
|
|
describe acquired hyperammonia
|
liver disease (caused by cirhossis, hepatitis), causes NH3 to accumulate in bloodstream
|
|
describe some consequences of NH3 toxicity
|
disruption of ion channels, decreased ATP generation (due to increased glutamate synthesis depleting alpha-ketoglutarate of the TCA)
|
|
describe hepatic encephalopathy
|
hepatic dysfunction causes accumulation of toxins, which reach brain and cause cognitive anomalies
|
|
compare male vs female metabolism of alcohol
|
most metabolism takes place in liver, but 15-20% metabolized in stomach, but this only true for males
|
|
describe three metabolic pathways for ethanol
|
1. alcohol dehydrogenase to acetaldehyde dehydrogenase to acetic acid; 2. microsomal alcohol oxidizing system (MAOS) -- EtOH activates CYP450 and affects drug metabolism; 3. catalase converts EtOH to acethaldehydes
|
|
three consequences of liver exposure to EtOH
|
steatosis (fatty liver), hepatitis, cirrhosis
|
|
define primary and secondary hemostatis
|
1. vasoconstriction and platelet seal; 2. coagulation to form blood clot
|
|
describe platelet seal formation
|
1. platlet binds to exposed collagen, 2. activation of platelet, 3a. shape change, pseudopodia form, enhanced adherence, 3b. secretion of ADP and thromboxane A2 to enhance activation/adherance
|
|
name two drugs interfering with platelet function
|
aspirin blocks thromboxane A2, plavix competitively inhibits ADP
|
|
how do undamaged ECs keep platelets from aggregating
|
secretion of prostagladin 2
|
|
how is intrinsic clotting pathway initiated
|
damage to endothelium activates kallikrein
|
|
describe intrinsic pathway cascade down to common source
|
damaged tissue components disturb factor XII to activate it > 11 > 9 > 10 -> IX is stabilized by XIII (stablized by vWF)
|
|
describe common pathway
|
activated factor X acts with factor V to get thrombin, then makes fibrin, and XIII act with fibrin to get clots and XB
|
|
describe extrinsic pathway
|
tissue trauma activates tissue trauma factor (III) to activate factor VII -- this activates factor X
|
|
what does thrombin do
|
activate fibrin, and factor V and factor VIII
|
|
describe the function of thrombin
|
1. activates fibronogen, 2. activates factor V and VIII, 3. cleaves/inactivates active forms V and VIII
|
|
describe two methods of limiting clotting
|
1. throbomodulin binds thrombin, activates protein C, and degrades V and VIII, 2. antithrombin degrades active proteases, activity enhanced by heparin, 3. thrombin resorbed into forming fibrin
|
|
what is important ion in clotting cascade
|
calcium is required
|
|
what clotting things is vitamin K important in
|
X, VII, IX, prothrombin, protein C
|
|
how would vitamin K deficiency occur
|
inability to resorb fats, liver disease, bile obstruction
|
|
describe pathology of hemophilia
|
deficient in factor VIII or IX, x-linked recessive
|
|
what are the anticoagulant factors/proteins
|
protein C, thrombomodulin, antithrombin, heparin, plasmin
|
|
describe hereditary thrombophilia
|
hypercoagulation caused by 1) mutated factor V, 2) elevated prothrombin expression, 3) decreased anticoagulant factors
|
|
describe pathogenesis of DIC
|
small clots form in blood vessels, depletes all platelets, then excessive bleeding in other parts
|
|
describe structure of the hepatocyte functional unit
|
central vein surrounded by portal vein/hepatic artery/bile duct (portal triad); central vein is area of low O2, bile duct is area of high O2
|
|
what is th dual blood supply to the liver
|
hepatic artery and portal vein
|
|
what are four sites affected by portal hypertension
|
1) rectal varices, 2) esophageal/gastric varices, 3) splenomegaly, 4) caput medusae (umbilical veins)
|
|
describe bile production
|
1) secretion of bile salts/cholesterol into bile canaliculi, 2) ducts/ductules add secretions (HCO3), 3) gallbladder can store/concentrate
|
|
where is bile and fat-soluble vitamins resorbed
|
terminal ileum
|
|
what is primary component of bile
|
bile salts
|
|
what is precursor to bile
|
cholesterol
|
|
what are the only types of energy brain can use
|
glucose and ketones (free fatty acids can be converted to ketones)
|
|
what cell secretes intrinsic factor
|
parietal cell
|